# Real-world Data of Nivolumab in Pre-treated NSCLC

> **NCT04713462** · — · COMPLETED · sponsor: **Hellenic Cooperative Oncology Group** · enrollment: 346 (actual)

## Conditions studied

- Non Small Cell Lung Cancer

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT04713462
- **Lead sponsor:** Hellenic Cooperative Oncology Group
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2015-10
- **Primary completion:** 2019-11
- **Final completion:** 2020-11
- **Target enrollment:** 346 (ACTUAL)
- **Last updated:** 2021-01-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04713462

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04713462, "Real-world Data of Nivolumab in Pre-treated NSCLC". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT04713462. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*